As whole-body deletion of PTP1B was proven to be beneficial in improving global insulin sensitivity, glucose homeostasis and conferred resistance to HFD-induced obesity, the tissue responsible for PTP1B effects remained questionable. This evidence concerns the gene INS and Obesity.